middle.news
How Resonance Health Plans to Quadruple Revenue by FY26
11:51am on Thursday 13th of November, 2025 AEDT
•
Healthcare
Read Story
How Resonance Health Plans to Quadruple Revenue by FY26
11:51am on Thursday 13th of November, 2025 AEDT
Key Points
Revenue expected to grow from $4.4M in FY23 to ~$17M by FY26
Underlying operating EBITDA forecasted at $2M with margin expansion targets
Expansion into new therapeutic areas including metabolic diseases and oncology
Geographic growth planned across Australia, US, Europe, China, and India
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE